ELK3 and central nervous system cancer: ELK3 expression is reportedly higher in 1p/19q non-codeletion and IDH wild-type gliomas than in other gliomas types, suggesting that ELK3 expression is positively correlated with the malignant degree of gliomas (30, 31).